[Tongxinluo improves vascular endothelial function in patients with type 2 diabetes]

Area of Science:

• Cardiovascular Research
• Endocrinology
• Pharmacology

Context:

• Type 2 diabetes mellitus (T2DM) is associated with significant vascular endothelial dysfunction.
• Endothelial dysfunction contributes to the increased cardiovascular risk in diabetic patients.
• Traditional Chinese medicine (TCM) offers potential therapeutic avenues for managing T2DM complications.

Purpose:

• To evaluate the efficacy of Tongxinluo in improving vascular endothelial function in patients with type 2 diabetes.
• To assess the impact of Tongxinluo on key endothelial markers and arterial diastolic function.
• To investigate the underlying mechanisms of Tongxinluo's action on the nitric oxide/endothelin balance.

Summary:

• A 4-week study involving 80 type 2 diabetes patients demonstrated that Tongxinluo therapy significantly enhanced flow-mediated dilation compared to conventional therapy.
• Tongxinluo treatment led to a significant increase in plasma nitric oxide (NO) and a significant reduction in plasma endothelin (ET) levels.
• No significant changes in vascular function or endothelial markers were observed in the placebo group, highlighting Tongxinluo's specific effects.

Impact:

• Tongxinluo effectively improves vascular endothelial-dependent diastolic function in type 2 diabetes patients.
• The therapeutic benefits of Tongxinluo are attributed to its ability to restore the balance between plasma NO and ET.
• These findings suggest Tongxinluo as a potential therapeutic agent for mitigating vascular complications in type 2 diabetes.